Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Quipt Home Medical Corp (QIPT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: QIPT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $3.6
1 Year Target Price $3.6
| 3 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -60.3% | Avg. Invested days 18 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 116.86M USD | Price to earnings Ratio - | 1Y Target Price 3.6 |
Price to earnings Ratio - | 1Y Target Price 3.6 | ||
Volume (30-day avg) 5 | Beta 0.26 | 52 Weeks Range 1.35 - 3.27 | Updated Date 09/14/2025 |
52 Weeks Range 1.35 - 3.27 | Updated Date 09/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.24 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -4.23% | Operating Margin (TTM) -4.41% |
Management Effectiveness
Return on Assets (TTM) -1.04% | Return on Equity (TTM) -9.51% |
Valuation
Trailing PE - | Forward PE 56.82 | Enterprise Value 196747750 | Price to Sales(TTM) 0.49 |
Enterprise Value 196747750 | Price to Sales(TTM) 0.49 | ||
Enterprise Value to Revenue 0.83 | Enterprise Value to EBITDA 4.12 | Shares Outstanding 43444000 | Shares Floating 34533179 |
Shares Outstanding 43444000 | Shares Floating 34533179 | ||
Percent Insiders 15.27 | Percent Institutions 48.25 |
Upturn AI SWOT
Quipt Home Medical Corp
Company Overview
History and Background
Quipt Home Medical Corp. (QIPT) was founded with a focus on providing durable medical equipment (DME) and respiratory services to patients in the United States. It has grown through strategic acquisitions and organic expansion.
Core Business Areas
- Respiratory Equipment: Providing respiratory equipment like CPAP machines, ventilators, and oxygen concentrators.
- Durable Medical Equipment (DME): Supplying DME such as mobility aids, hospital beds, and other medical devices.
- Home Healthcare Services: Offering home healthcare services, including equipment setup, patient education, and ongoing support.
Leadership and Structure
The company has a management team focused on operational efficiency and growth through acquisitions. Details on specific leadership and organizational structure are available in their investor relations section.
Top Products and Market Share
Key Offerings
- CPAP/BiPAP Machines: Devices for treating sleep apnea. Competitors include ResMed (RMD) and Philips Respironics. Market share data is difficult to ascertain exactly, but QIPT is a significant player.
- Oxygen Concentrators: Equipment for providing supplemental oxygen. Competitors include Inogen (INGN) and Invacare (IVC). Market share is competitive and fragmented.
- Mobility Equipment: Wheelchairs, walkers, and other mobility aids. Competitors include Permobil and Invacare (IVC). Revenue generated from this segment has grown significantly with demographic trends and acquisitions
Market Dynamics
Industry Overview
The DME and home healthcare market is growing due to an aging population, increasing prevalence of chronic diseases, and a shift towards home-based care.
Positioning
Quipt Home Medical Corp. is positioned as a consolidator in the fragmented DME market, focusing on acquiring smaller players and improving operational efficiency. Their competitive advantage lies in their geographic reach, established infrastructure, and ability to integrate acquisitions effectively.
Total Addressable Market (TAM)
The total addressable market for DME and home healthcare is substantial, estimated at hundreds of billions of dollars. Quipt Home Medical Corp is strategically positioned to capture a greater market share through continued acquisitions and organic growth.
Upturn SWOT Analysis
Strengths
- Strong acquisition strategy
- Established infrastructure
- Geographic reach
- Focus on operational efficiency
- Growing revenue
Weaknesses
- High debt levels due to acquisitions
- Integration risks from acquisitions
- Dependence on reimbursement rates
- Competition from larger players
Opportunities
- Further consolidation of the DME market
- Expansion into new geographic areas
- Growth in telehealth and remote patient monitoring
- Increasing demand for home healthcare services
Threats
- Changes in reimbursement policies
- Increased competition
- Economic downturn
- Supply chain disruptions
- Rising interest rates affecting acquisition costs
Competitors and Market Share
Key Competitors
- RMD
- INGN
- IVC
- LHCG
- AMCR
Competitive Landscape
Quipt Home Medical Corp. competes with larger, more established players in the DME market. Its advantage lies in its agility and focus on acquiring and integrating smaller companies. However, it faces challenges in competing on price and scale with larger players.
Major Acquisitions
Great Elm Healthcare
- Year: 2021
- Acquisition Price (USD millions): 80
- Strategic Rationale: Expanded Quipt's geographic presence and strengthened its product offerings.
Access Respiratory Homecare
- Year: 2020
- Acquisition Price (USD millions): 25.9
- Strategic Rationale: Increased Quipt's market share and revenue base.
Growth Trajectory and Initiatives
Historical Growth: Quipt Home Medical Corp. has experienced rapid growth through acquisitions.
Future Projections: Analyst estimates project continued revenue growth driven by acquisitions and organic expansion. However, profitability may be affected by interest expense and integration costs.
Recent Initiatives: Recent initiatives include strategic acquisitions to expand market presence and investment in technology to improve operational efficiency.
Summary
Quipt Home Medical Corp. is a growing company in the fragmented DME market, focusing on acquisitions to expand its reach. Its growth is strong but has high debt. It needs to manage its debt and integrate acquisitions successfully to achieve sustainable profitability. Changes in reimbursement policies are a threat to watch.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC filings (10-K, 10-Q), Company press releases, Analyst reports, Industry publications
Disclaimers:
This analysis is for informational purposes only and does not constitute investment advice. Financial data is subject to change, and past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Quipt Home Medical Corp
Exchange NASDAQ | Headquaters Wilder, KY, United States | ||
IPO Launch date 2021-05-27 | Chairman, President & CEO Mr. Gregory J. Crawford | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 1150 | Website https://quipthomemedical.com |
Full time employees 1150 | Website https://quipthomemedical.com | ||
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.